Editor
The only drug available to treat monkeypox is so difficult to access that just a fraction of the nearly 7,000 U.S. patients have been given it.
Health officials have designated tecovirimat, also called Tpoxx, an “investigational drug,” which they say means it cannot be released from the strategic national stockpile without a series of convoluted bureaucratic steps. But most doctors do not have the time or resources to fill out the…
